Photo 1 sur 1

Galerie
Photo 1 sur 1

Vous en avez un à vendre?
Glucagon I par T.T. Livre de poche Aoki (anglais)
189,57 $US
Environ261,34 $C
État :
Entièrement neuf
Un livre neuf, non lu, non utilisé et en parfait état, sans aucune page manquante ni endommagée.
Oops! Looks like we're having trouble connecting to our server.
Refresh your browser window to try again.
Expédition :
Sans frais Economy Shipping.
Lieu : Fairfield, Ohio, États-Unis
Livraison :
Livraison prévue entre le mar. 19 août et le jeu. 28 août à 94104
Renvois :
Renvoi sous 30 jours. L'acheteur paie les frais de renvoi. Si vous utilisez une étiquette d'envoi eBay, son coût sera déduit du montant de votre remboursement.
Paiements :
Magasinez en toute confiance
Le vendeur assume l'entière responsabilité de cette annonce.
Numéro de l'objet eBay :395147294554
Dernière mise à jour : janv. 28, 2025 19:15:48 HNEAfficher toutes les modificationsAfficher toutes les modifications
Caractéristiques de l'objet
- État
- ISBN-13
- 9783642688683
- Book Title
- Glucagon I
- ISBN
- 9783642688683
À propos de ce produit
Product Identifiers
Publisher
Springer Berlin / Heidelberg
ISBN-10
3642688683
ISBN-13
9783642688683
eBay Product ID (ePID)
144006145
Product Key Features
Number of Pages
Xxx, 536 Pages
Language
English
Publication Name
Glucagon I
Publication Year
2011
Subject
Life Sciences / Biochemistry, Pharmacy, Pharmacology
Type
Textbook
Subject Area
Science, Medical
Series
Handbook of Experimental Pharmacology Ser.
Format
Trade Paperback
Dimensions
Item Height
0.5 in
Item Weight
34.8 Oz
Item Length
9.6 in
Item Width
6.7 in
Additional Product Features
Intended Audience
Scholarly & Professional
Series Volume Number
66 / 1
Number of Volumes
1 vol.
Illustrated
Yes
Table Of Content
Chemistry and Physicochemistry of Glucagon.- 1 Chemical Characteristics of Glucagon.- 2 The Chemical Synthesis of Glucagon.- 3 The Conformation of Glucagon.- Morphology of the A-cell of Islets of Langerhans, Biosynthesis of Glucagon and Related Peptides.- 4 Glucagon- and Glicentin-Producing Cells.- 5 Ontogeny and Phylogeny of the Glucagon Cell.- 6 The Biosynthesis of Glucagon.- 7 Glucagon, Glicentin, and Related Peptides.- Production and Assay of Glucagon.- 8 Glucagon Preparations.- 9 The Immunogenicity of Glucagon.- 10 Immunoassays for Glucagon.- 11 Heterogeneity of Circulating Glucagon and Glucagon-Like Immunoreactivity.- 12 Radioreceptorassays for Glucagon.- Actions of Glucagon.- 13 The Actions of Glucagon at Its Receptor: Regulation of Adenylate Cyclase.- 14 Glucagon and Liver Glycogen Metabolism.- 15 Glucagon and Gluconeogenesis.- 16 Glucagon and Liver Glucose Output In Vivo.- 17 Glucagon and Ketogenesis.- 18 Glucagon and Amino Acid Metabolism.- 19 Glucagon and Adipose Tissue Lipolysis.- 20 Glucagon and Lipoprotein Metabolism.- 21 Glucagon and Liver Regeneration.- 22 Glucagon and Insulin Secretion.
Synopsis
The Editorial Board of the Handbook of Experimental Pharmacology apparently did not hurry in suggesting production of a volume on glucagon since the present opus is number sixty-six in the series. This fact is even more striking if we consider that 34 volumes published over about eight years will separate the books on glucagon from those on insulin on library shelves, whereas only a few microns separate the cells manufacturing these two polypeptides within the islets of Langerhans in the pancreas! Numerous factors have probably caused this dicrimination; four of them are: First, insulin deficiency or resistance is the cause of one of the most serious and distressing diseases, diabetes mellitus, which affects millions of people, whereas glucagon deficiency is apparently an extremely rare disorder, for which detailed reports are published of individual cases whenever they occur. Second, since its discovery in 1921 by BANTING and BEST, insulin has been irreplaceable for the treatment of the most severe forms of diabetes, whereas, in contrast, glucagon was until recently considered a relatively minor therapeutic agent. Third, whereas insulin is a compound which has been well characterized since the pioneering work of SANGER and its biosynthesis clearly identified by STEINER and his co-workers, glucagon, also well characterized chemically, has suffered from its parenthood with the so-called "glucagon-like immunoreactive substances", an incompletely defined series of immunologically related polypeptides present in the gut, the pancreas and some other parts of the body., The Editorial Board of the Handbook of Experimental Pharmacology apparently did not hurry in suggesting production of a volume on glucagon since the present opus is number sixty-six in the series. This fact is even more striking if we consider that 34 volumes published over about eight years will separate the books on glucagon from those on insulin on library shelves, whereas only a few microns separate the cells manufacturing these two polypeptides within the islets of Langerhans in the pancreas Numerous factors have probably caused this dicrimination; four of them are: First, insulin deficiency or resistance is the cause of one of the most serious and distressing diseases, diabetes mellitus, which affects millions of people, whereas glucagon deficiency is apparently an extremely rare disorder, for which detailed reports are published of individual cases whenever they occur. Second, since its discovery in 1921 by BANTING and BEST, insulin has been irreplaceable for the treatment of the most severe forms of diabetes, whereas, in contrast, glucagon was until recently considered a relatively minor therapeutic agent. Third, whereas insulin is a compound which has been well characterized since the pioneering work of SANGER and its biosynthesis clearly identified by STEINER and his co-workers, glucagon, also well characterized chemically, has suffered from its parenthood with the so-called "glucagon-like immunoreactive substances", an incompletely defined series of immunologically related polypeptides present in the gut, the pancreas and some other parts of the body.
LC Classification Number
RM300-666
Description de l'objet du vendeur
Évaluations comme vendeur (1 054 731)
- w***i (873)- Évaluation laissée par l'acheteur.Dernier moisAchat vérifiéAbsolutely Wonderful Seller!! Terrific Item As Described!!! Great Service and Communication!! Shipped In Waterproof Packaging!! I Received Item In About One Week!! Very Pleased With Seller! I Will Buy From This Seller Again!!
- e***_ (17)- Évaluation laissée par l'acheteur.Six derniers moisAchat vérifiéSeller handles a massive inventory so I give them grace on the slow processing and shipping. They were very communicative and prompt with their response when I messaged in asking about it. Book was in good condition as described. Small ding on the page edges which wasn't mentioned, but that's fairly common even at your typical book store. Still a good value and I'd buy from them again.
- r***r (2963)- Évaluation laissée par l'acheteur.Six derniers moisAchat vérifiéBook arrived today, 2 days before deadline given by the seller. Well-packaged & in good condition. Price was very competitive, & the book was accurately listed. Great communication. I appreciate the seller getting back to me when I was having trouble tracking the book's delivery progress. Apparently there were 2 different tracking numbers - one in Canada & the other in the U.S., since it was initially shipped from Canada. Thank you very much for your quick response & helpful information.Rethinking Investing: A Very Short Guide to Very Long-Term Investing by Charles (#396183075510)